Recently, it was shown that p53 may either promote or antagonize the anti-proliferating effect of B02 alone or in combination with topotecan in retinoblastoma cells depending on whether the BAX (apoptotic) or p21 (G1 cell cycle arrest) pathways predominate in these cells [79]. The gene discussed is BAX; the disease is retinoblastoma.